TABLE IV

Derivation of the Hazard Threshold (HT)

ExtractableCAS RNBasis for HTRef.Values for Uncertainty Factors
UF1UF2UF3UF4
Silicic acid10193-36-9NOAEL for soluble silicates (rat, oral, 90 days); 227 mg/kg/day31105510
Dodecamethylpentasiloxane141-63-9NOEL (rat, oral, 28 days); 1500 mg/kg/day7105104
Tetradecamethylheptasiloxane19095-23-9Read across from 141-63-9
Methycyclohexylsilanediol18295-72-2NOEL (rat, oral, read across from cyclohexyl-dimethoxymethylsilane, 17865-32-6); 62.5 mg/kg/day8105105
1,1-Dicyclopentylsilanediol211495-85-1NOEL (rat, oral, 90 day repeat dose); 40 mg/kg/day910555
Benzoic acid65-85-0NOAEL (rat, oral, 4 generation study); 750 mg/kg/day1010511
Nonanoic acid112-05-0LD50 (mouse, i.v.); 224 mg/kg/day111012251
Lactic acid50-21-5NOAEL (mouse, oral, maternal toxicity/teratogenicity); 570 mg/kg/day13101252
Myristic acid544-63-8LD50 (rat, oral); 10000 mg/kg/day131052510
Pentadecanoic acid1002-84-2Read across from 112-05-0
Palmitic acid57-10-3LD50 (rat, oral); 10000 mg/kg/day14105252
Oleic acid112-80-1NOAEL (rat, oral); 7500 mg/kg/day15105102
Stearic acid57-11-4LD50 (human, oral); 14286 mg/kg/day161012510
7,9-Di-tert-butyl-1-oxaspiro(4,5)-deca-6,9-diene-2,8-dione82304-66-3Read across from 20170-32-5
Methyl-3-[4-hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]-propanoate6386-38-5Read across from 20170-32-5
3-(3-5-di-tert-butyl-1-hydroxy-4-oxo-2,5-cyclohexadiene-1-yl)propanoic acid83237-15-4Read across from 20170-32-5
3,5-Bis(1,1-dimethylethyl)-4-hydroxy-benzenepropanoic acid20170-32-5NOAEL (rat, oral, 13 week); 50 mg/kg/day7105510
2,6-Di-tert-butyl-4-methylene-cyclohexa-2,5-dien-1-one2607-52-5Read across from 20170-32-5
2,4-Di-tert-butylphenol96-76-4NOAEL (rat, oral, 28 day); 75 mg/kg/day17105510
Butylated Hydroxytoluene (BHT)128-37-0NOAEL (mouse, oral, 21 day); 660 mg/kg/day18, 191012101
Irgafos 168 Phosphate95906-11-9Read across from Irgafos 168 (31570-04-4): LOAEL (rat, oral, 2-generation); 107 mg/kg/day20105110
Erucamide + related substances112-84-5NOAEL (rat, oral, 4 week); 7100 mg/kg/day21105105
Hexadecanamide629-54-9NOAEL (rat, oral, maternal and fetal); 1000 mg/kg/day7105110
9-Octadeceneamide301-02-0NOAEL (rat, oral, 5 days); 100 mg/kg/day71051010
Urea57-13-6LDLo (mouse, i.v.); 4600 mg/kg/day221012155
Glycerol56-81-5NOAEL (rat, oral); 10,000 mg/kg/day231051010
Ethyl-4-ethoxybenzoate23676-09-7LD50 (rat, oral, acute); 1649 mg/kg/day71052510
1,4-Dithioerythritol3483-12-3LD50 (rat, oral); 400 mg/kg241052510
Dodecanol112-53-8NOAEL (rat, oral, 37 day); 100 mg/kg/day25105101
Dodecyl acrylate2156-97-0NOAEL (rat, oral, sub-chronic, read across from butyl acrylate); 84 mg/kg/day26105510
Dibutyl phthalate84-74-2LOAEL (rat, oral, 21 days); 1047 mg/kg/day271051010
Diethyl phthalate84-66-2NOAEL (mouse, oral, 2 weeks); 10,000 mg/kg/day2810121010
Stearyl alcohol112-92-5NOAEL (rat, oral, 28 days); 1000 mg/kg/day29105104
Ethoxylated Amines (total), Atmer 16371786-60-2TDLo (rat, oral); 500 mg/kg/day301051510